Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed Jun 2, 2017 · 10-Q · 63 days after period end · 0001615774-17-002868
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $268.93K | — | $10.77K |
| Net Income | -$613.90K | -$851.24K | -$151.80K |
| EPS Diluted | -$0.01 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Jun 2, 2017 · 63 d after period end
